Initial Experience of Clinical Use of [<sup>99m</sup>Tc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study

Numerous different molecules of prostate-specific membrane antigen (PSMA) ligands are used to detect prostate cancer (PCa); most approaches utilize gallium PET and a few reports describe the role of SPECT/CT. [<sup>99m</sup>Tc]Tc-PSMA-T4 is a new radiopharmaceutical designed for the diag...

Full description

Saved in:
Bibliographic Details
Main Authors: Jarosław B. Ćwikła, Marek Roslan, Iwona Skoneczna, Monika Kempińska-Wróbel, Michał Maurin, Wojciech Rogowski, Barbara Janota, Anna Szarowicz, Piotr Garnuszek
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
R
Online Access:https://doaj.org/article/a0e5ca092f78461a9d09f2c9eaa41c14
Tags: Add Tag
No Tags, Be the first to tag this record!